265 related articles for article (PubMed ID: 24512919)
1. Identification and validation of novel candidate protein biomarkers for the detection of human gastric cancer.
Humphries JM; Penno MA; Weiland F; Klingler-Hoffmann M; Zuber A; Boussioutas A; Ernst M; Hoffmann P
Biochim Biophys Acta; 2014 May; 1844(5):1051-8. PubMed ID: 24512919
[TBL] [Abstract][Full Text] [Related]
2. Proteomic profiling identifies afamin as a potential biomarker for ovarian cancer.
Jackson D; Craven RA; Hutson RC; Graze I; Lueth P; Tonge RP; Hartley JL; Nickson JA; Rayner SJ; Johnston C; Dieplinger B; Hubalek M; Wilkinson N; Perren TJ; Kehoe S; Hall GD; Daxenbichler G; Dieplinger H; Selby PJ; Banks RE
Clin Cancer Res; 2007 Dec; 13(24):7370-9. PubMed ID: 18094419
[TBL] [Abstract][Full Text] [Related]
3. S100A9, GIF and AAT as potential combinatorial biomarkers in gastric cancer diagnosis and prognosis.
Wu W; Juan WC; Liang CR; Yeoh KG; So J; Chung MC
Proteomics Clin Appl; 2012 Apr; 6(3-4):152-62. PubMed ID: 22532451
[TBL] [Abstract][Full Text] [Related]
4. Proteomic identification of serum biomarkers for gastric cancer using multi-dimensional liquid chromatography and 2D differential gel electrophoresis.
Liu W; Liu B; Cai Q; Li J; Chen X; Zhu Z
Clin Chim Acta; 2012 Jul; 413(13-14):1098-106. PubMed ID: 22446497
[TBL] [Abstract][Full Text] [Related]
5. Plasma clusterin as a candidate pre-diagnosis marker of colorectal cancer risk in the Florence cohort of the European Prospective Investigation into Cancer and Nutrition: a pilot study.
Bertuzzi M; Marelli C; Bagnati R; Colombi A; Fanelli R; Saieva C; Ceroti M; Bendinelli B; Caini S; Airoldi L; Palli D
BMC Cancer; 2015 Feb; 15():56. PubMed ID: 25884309
[TBL] [Abstract][Full Text] [Related]
6. 2D-DIGE analysis of sera from transgenic mouse models reveals novel candidate protein biomarkers for human gastric cancer.
Penno MA; Klingler-Hoffmann M; Brazzatti JA; Boussioutas A; Putoczki T; Ernst M; Hoffmann P
J Proteomics; 2012 Dec; 77():40-58. PubMed ID: 22789672
[TBL] [Abstract][Full Text] [Related]
7. Discovery of gastric cancer specific biomarkers by the application of serum proteomics.
Yoo MW; Park J; Han HS; Yun YM; Kang JW; Choi DY; Lee JW; Jung JH; Lee KY; Kim KP
Proteomics; 2017 Mar; 17(6):. PubMed ID: 28133907
[TBL] [Abstract][Full Text] [Related]
8. Down-regulated expression of complement factor I: a potential suppressive protein for gastric cancer identified by serum proteome analysis.
Liu W; Liu B; Xin L; Zhang Y; Chen X; Zhu Z; Lin Y
Clin Chim Acta; 2007 Feb; 377(1-2):119-26. PubMed ID: 17067565
[TBL] [Abstract][Full Text] [Related]
9. Identification of tubulin beta chain, thymosin beta-4-like protein 3, and cytochrome b-c₁ complex subunit 1 as serological diagnostic biomarkers of gastric cancer.
Fan NJ; Li K; Liu QY; Wang XL; Hu L; Li JT; Gao CF
Clin Biochem; 2013 Oct; 46(15):1578-84. PubMed ID: 23747515
[TBL] [Abstract][Full Text] [Related]
10. Novel proteomic strategy reveal combined alpha1 antitrypsin and cathepsin D as biomarkers for colorectal cancer early screening.
Xie LQ; Zhao C; Cai SJ; Xu Y; Huang LY; Bian JS; Shen CP; Lu HJ; Yang PY
J Proteome Res; 2010 Sep; 9(9):4701-9. PubMed ID: 20666480
[TBL] [Abstract][Full Text] [Related]
11. Identification of a high molecular weight kininogen fragment as a marker for early gastric cancer by serum proteome analysis.
Umemura H; Togawa A; Sogawa K; Satoh M; Mogushi K; Nishimura M; Matsushita K; Tanaka H; Takizawa H; Kodera Y; Nomura F
J Gastroenterol; 2011 May; 46(5):577-85. PubMed ID: 21298293
[TBL] [Abstract][Full Text] [Related]
12. Identification of haptoglobin peptide as a novel serum biomarker for lung squamous cell carcinoma by serum proteome and peptidome profiling.
Okano T; Seike M; Kuribayashi H; Soeno C; Ishii T; Kida K; Gemma A
Int J Oncol; 2016 Mar; 48(3):945-52. PubMed ID: 26783151
[TBL] [Abstract][Full Text] [Related]
13. Identification of carboxyl terminal peptide of Fibrinogen as a potential serum biomarker for gastric cancer.
Wu C; Luo Z; Tang D; Liu L; Yao D; Zhu L; Wang Z
Tumour Biol; 2016 May; 37(5):6963-70. PubMed ID: 26662807
[TBL] [Abstract][Full Text] [Related]
14. Serum olfactomedin 4 (GW112, hGC-1) in combination with Reg IV is a highly sensitive biomarker for gastric cancer patients.
Oue N; Sentani K; Noguchi T; Ohara S; Sakamoto N; Hayashi T; Anami K; Motoshita J; Ito M; Tanaka S; Yoshida K; Yasui W
Int J Cancer; 2009 Nov; 125(10):2383-92. PubMed ID: 19670418
[TBL] [Abstract][Full Text] [Related]
15. Qualification and Verification of Serological Biomarker Candidates for Lung Adenocarcinoma by Targeted Mass Spectrometry.
Wu HY; Goan YG; Chang YH; Yang YF; Chang HJ; Cheng PN; Wu CC; Zgoda VG; Chen YJ; Liao PC
J Proteome Res; 2015 Aug; 14(8):3039-50. PubMed ID: 26120931
[TBL] [Abstract][Full Text] [Related]
16. Serum proteomic profiling of lung cancer in high-risk groups and determination of clinical outcomes.
Jacot W; Lhermitte L; Dossat N; Pujol JL; Molinari N; Daurès JP; Maudelonde T; Mangé A; Solassol J
J Thorac Oncol; 2008 Aug; 3(8):840-50. PubMed ID: 18670301
[TBL] [Abstract][Full Text] [Related]
17. Detection of autoantibodies to a panel of tumor-associated antigens for the diagnosis values of gastric cardia adenocarcinoma.
Zhou SL; Ku JW; Fan ZM; Yue WB; Du F; Zhou YF; Liu YL; Li Y; Tang S; Hu YL; Hu XP; Hou ZC; Liu J; Liu Y; Feng XS; Wang LD
Dis Esophagus; 2015; 28(4):371-9. PubMed ID: 24612004
[TBL] [Abstract][Full Text] [Related]
18. Discovery and Validation of Serum Autoantibodies Against Tumor-Associated Antigens as Biomarkers in Gastric Adenocarcinoma Based on the Focused Protein Arrays.
Yang Q; Qin J; Sun G; Qiu C; Jiang D; Ye H; Wang X; Dai L; Zhu J; Wang P; Zhang J
Clin Transl Gastroenterol; 2020 Dec; 12(1):e00284. PubMed ID: 33346593
[TBL] [Abstract][Full Text] [Related]
19. Identification of ovarian cancer-associated proteins in symptomatic women: A novel method for semi-quantitative plasma proteomics.
Shield-Artin KL; Bailey MJ; Oliva K; Liovic AK; Barker G; Dellios NL; Reisman S; Ayhan M; Rice GE
Proteomics Clin Appl; 2012 Apr; 6(3-4):170-81. PubMed ID: 22532453
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic role of serum protein peak at 6449 m/z in gastric adenocarcinoma based on mass spectrometry.
Song D; Yue L; Li H; Zhang J; Yan Z; Fan Y; Yang H; Liu Q; Zhang D; Xia Z; Qin P; Jia J; Yue M; Yu J; Zheng S; Yang F; Wang J
Br J Cancer; 2016 Apr; 114(8):929-38. PubMed ID: 27002935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
